Does the media refer more to CBLL or KRMD?

In the previous week, CeriBell had 1 more articles in the media than KORU Medical Systems. MarketBeat recorded 9 mentions for CeriBell and 8 mentions for KORU Medical Systems. CeriBell's average media sentiment score of 0.68 beat KORU Medical Systems' score of 0.45 indicating that CeriBell is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CeriBell 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive KORU Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to KRMD or TCMD?

In the previous week, KORU Medical Systems had 2 more articles in the media than Tactile Systems Technology. MarketBeat recorded 8 mentions for KORU Medical Systems and 6 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.82 beat KORU Medical Systems' score of 0.45 indicating that Tactile Systems Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Tactile Systems Technology 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BWAY or KRMD?

In the previous week, KORU Medical Systems had 4 more articles in the media than Brainsway. MarketBeat recorded 8 mentions for KORU Medical Systems and 4 mentions for Brainsway. Brainsway's average media sentiment score of 1.06 beat KORU Medical Systems' score of 0.45 indicating that Brainsway is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Brainsway 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive KORU Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to KRMD or ANGO?

In the previous week, AngioDynamics had 9 more articles in the media than KORU Medical Systems. MarketBeat recorded 17 mentions for AngioDynamics and 8 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 0.45 beat AngioDynamics' score of -0.05 indicating that KORU Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral AngioDynamics 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to KRMD or BBNX?

In the previous week, KORU Medical Systems had 5 more articles in the media than Beta Bionics. MarketBeat recorded 8 mentions for KORU Medical Systems and 3 mentions for Beta Bionics. Beta Bionics' average media sentiment score of 0.80 beat KORU Medical Systems' score of 0.45 indicating that Beta Bionics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment KORU Medical Systems 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Beta Bionics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

KORU Medical Systems (KRMD) Competitors

$3.40 -0.15 (-4.23%)

As of 04:00 PM Eastern

Compare

KRMD vs. CBLL, TCMD, BWAY, ANGO, and BBNX

Should you buy KORU Medical Systems stock or one of its competitors? KORU Medical Systems's main competitors and comparable companies include CeriBell (CBLL), Tactile Systems Technology (TCMD), Brainsway (BWAY), AngioDynamics (ANGO), and Beta Bionics (BBNX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does KORU Medical Systems compare to CeriBell?

CeriBell (NASDAQ:CBLL) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, profitability, analyst recommendations, valuation, earnings and dividends.

In the previous week, CeriBell had 1 more articles in the media than KORU Medical Systems. MarketBeat recorded 9 mentions for CeriBell and 8 mentions for KORU Medical Systems. CeriBell's average media sentiment score of 0.68 beat KORU Medical Systems' score of 0.45 indicating that CeriBell is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CeriBell	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

KORU Medical Systems has a net margin of -4.03% compared to CeriBell's net margin of -63.51%. KORU Medical Systems' return on equity of -10.63% beat CeriBell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CeriBell	-63.51%	-38.19%	-30.92%
KORU Medical Systems	-4.03%	-10.63%	-6.51%

KORU Medical Systems has lower revenue, but higher earnings than CeriBell. KORU Medical Systems is trading at a lower price-to-earnings ratio than CeriBell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CeriBell	$89.06M	8.22	-$53.41M	-$1.63	N/A
KORU Medical Systems	$41.13M	3.80	-$2.64M	-$0.04	N/A

CeriBell presently has a consensus target price of $22.20, indicating a potential upside of 15.03%. KORU Medical Systems has a consensus target price of $7.00, indicating a potential upside of 105.88%. Given KORU Medical Systems' higher probable upside, analysts plainly believe KORU Medical Systems is more favorable than CeriBell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CeriBell	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

58.6% of KORU Medical Systems shares are owned by institutional investors. 17.7% of CeriBell shares are owned by insiders. Comparatively, 18.5% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

CeriBell has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market.

Summary

CeriBell and KORU Medical Systems tied by winning 8 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to Tactile Systems Technology?

KORU Medical Systems (NASDAQ:KRMD) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, media sentiment, profitability, dividends, risk and institutional ownership.

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

KORU Medical Systems has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market.

Tactile Systems Technology has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.80	-$2.64M	-$0.04	N/A
Tactile Systems Technology	$329.52M	2.00	$19.09M	$0.88	33.11

In the previous week, KORU Medical Systems had 2 more articles in the media than Tactile Systems Technology. MarketBeat recorded 8 mentions for KORU Medical Systems and 6 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.82 beat KORU Medical Systems' score of 0.45 indicating that Tactile Systems Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Tactile Systems Technology	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tactile Systems Technology has a net margin of 5.91% compared to KORU Medical Systems' net margin of -4.03%. Tactile Systems Technology's return on equity of 9.70% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Tactile Systems Technology	5.91%	9.70%	7.53%

KORU Medical Systems currently has a consensus target price of $7.00, suggesting a potential upside of 105.88%. Tactile Systems Technology has a consensus target price of $38.60, suggesting a potential upside of 32.46%. Given KORU Medical Systems' higher probable upside, equities research analysts clearly believe KORU Medical Systems is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

Tactile Systems Technology beats KORU Medical Systems on 11 of the 15 factors compared between the two stocks.

How does KORU Medical Systems compare to Brainsway?

Brainsway (NASDAQ:BWAY) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.

Brainsway presently has a consensus target price of $15.67, suggesting a potential upside of 2.26%. KORU Medical Systems has a consensus target price of $7.00, suggesting a potential upside of 105.88%. Given KORU Medical Systems' higher possible upside, analysts plainly believe KORU Medical Systems is more favorable than Brainsway.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Brainsway	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.17
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Brainsway has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market.

Brainsway has a net margin of 15.68% compared to KORU Medical Systems' net margin of -4.03%. Brainsway's return on equity of 12.28% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Brainsway	15.68%	12.28%	7.75%
KORU Medical Systems	-4.03%	-10.63%	-6.51%

Brainsway has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Brainsway	$52.22M	11.77	$7.57M	$0.35	43.77
KORU Medical Systems	$41.13M	3.80	-$2.64M	-$0.04	N/A

In the previous week, KORU Medical Systems had 4 more articles in the media than Brainsway. MarketBeat recorded 8 mentions for KORU Medical Systems and 4 mentions for Brainsway. Brainsway's average media sentiment score of 1.06 beat KORU Medical Systems' score of 0.45 indicating that Brainsway is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Brainsway	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

30.1% of Brainsway shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 19.0% of Brainsway shares are held by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Brainsway beats KORU Medical Systems on 14 of the 17 factors compared between the two stocks.

How does KORU Medical Systems compare to AngioDynamics?

KORU Medical Systems (NASDAQ:KRMD) and AngioDynamics (NASDAQ:ANGO) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

In the previous week, AngioDynamics had 9 more articles in the media than KORU Medical Systems. MarketBeat recorded 17 mentions for AngioDynamics and 8 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 0.45 beat AngioDynamics' score of -0.05 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
AngioDynamics	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

KORU Medical Systems has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.33, suggesting that its stock price is 67% less volatile than the broader market.

KORU Medical Systems has higher earnings, but lower revenue than AngioDynamics. KORU Medical Systems is trading at a lower price-to-earnings ratio than AngioDynamics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.80	-$2.64M	-$0.04	N/A
AngioDynamics	$320.17M	2.03	-$36.74M	-$0.87	N/A

KORU Medical Systems has a net margin of -4.03% compared to AngioDynamics' net margin of -11.48%. AngioDynamics' return on equity of -5.73% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
AngioDynamics	-11.48%	-5.73%	-3.77%

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 89.4% of AngioDynamics shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by insiders. Comparatively, 6.0% of AngioDynamics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

KORU Medical Systems presently has a consensus price target of $7.00, suggesting a potential upside of 105.88%. AngioDynamics has a consensus price target of $19.50, suggesting a potential upside of 23.81%. Given KORU Medical Systems' stronger consensus rating and higher possible upside, analysts clearly believe KORU Medical Systems is more favorable than AngioDynamics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
AngioDynamics	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.40

Summary

KORU Medical Systems beats AngioDynamics on 10 of the 17 factors compared between the two stocks.

How does KORU Medical Systems compare to Beta Bionics?

KORU Medical Systems (NASDAQ:KRMD) and Beta Bionics (NASDAQ:BBNX) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, profitability and earnings.

In the previous week, KORU Medical Systems had 5 more articles in the media than Beta Bionics. MarketBeat recorded 8 mentions for KORU Medical Systems and 3 mentions for Beta Bionics. Beta Bionics' average media sentiment score of 0.80 beat KORU Medical Systems' score of 0.45 indicating that Beta Bionics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
KORU Medical Systems	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Beta Bionics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

KORU Medical Systems presently has a consensus price target of $7.00, indicating a potential upside of 105.88%. Beta Bionics has a consensus price target of $20.10, indicating a potential upside of 22.56%. Given KORU Medical Systems' stronger consensus rating and higher probable upside, research analysts clearly believe KORU Medical Systems is more favorable than Beta Bionics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Beta Bionics	1 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.55

KORU Medical Systems has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market. Comparatively, Beta Bionics has a beta of 3.13, indicating that its share price is 213% more volatile than the broader market.

KORU Medical Systems has a net margin of -4.03% compared to Beta Bionics' net margin of -61.31%. KORU Medical Systems' return on equity of -10.63% beat Beta Bionics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Beta Bionics	-61.31%	-26.30%	-23.25%

KORU Medical Systems has higher earnings, but lower revenue than Beta Bionics. KORU Medical Systems is trading at a lower price-to-earnings ratio than Beta Bionics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	3.80	-$2.64M	-$0.04	N/A
Beta Bionics	$100.25M	7.36	-$73.20M	-$1.65	N/A

58.6% of KORU Medical Systems shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Comparatively, 5.3% of Beta Bionics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

KORU Medical Systems beats Beta Bionics on 10 of the 16 factors compared between the two stocks.

Get KORU Medical Systems News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KRMD vs. The Competition

Export

Metric	KORU Medical Systems	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$156.16M	$5.79B	$7.06B	$12.95B
Dividend Yield	N/A	1.78%	2.58%	10.20%
P/E Ratio	-85.00	24.71	269.75	24.74
Price / Sales	3.80	67.44	652.34	108.60
Price / Cash	N/A	33.55	28.89	37.44
Price / Book	9.19	6.21	11.27	6.42
Net Income	-$2.64M	$147.87M	$3.45B	$347.12M
7 Day Performance	-19.62%	3.40%	3.56%	2.48%
1 Month Performance	-20.56%	1.66%	-0.58%	-1.04%
1 Year Performance	-14.14%	6.26%	77.52%	23.22%

KORU Medical Systems Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KRMD KORU Medical Systems	3.6198 of 5 stars	$3.40 -4.2%	$7.00 +105.9%	-10.4%	$163.06M	$41.13M	N/A	80	Earnings Report Analyst Downgrade
CBLL CeriBell	2.4556 of 5 stars	$18.52 +1.1%	$22.20 +19.9%	+45.7%	$694.74M	$95.07M	N/A	N/A	News Coverage Earnings Report
TCMD Tactile Systems Technology	3.9246 of 5 stars	$30.14 +1.2%	$38.60 +28.1%	+140.2%	$671.72M	$329.52M	34.25	1,086	News Coverage Earnings Report
BWAY Brainsway	3.8986 of 5 stars	$15.80 -0.1%	$15.67 -0.8%	+163.6%	$634.47M	$52.22M	45.14	120	Positive News Upcoming Earnings
ANGO AngioDynamics	3.324 of 5 stars	$15.19 +0.1%	$19.50 +28.4%	+84.4%	$627.01M	$320.17M	N/A	760

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KRMD) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

KORU Medical Systems (KRMD) Competitors

KRMD vs. CBLL, TCMD, BWAY, ANGO, and BBNX

How does KORU Medical Systems compare to CeriBell?

Summary

How does KORU Medical Systems compare to Tactile Systems Technology?

Summary

How does KORU Medical Systems compare to Brainsway?

Summary

How does KORU Medical Systems compare to AngioDynamics?

Summary

How does KORU Medical Systems compare to Beta Bionics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KRMD vs. The Competition

KORU Medical Systems Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

KORU Medical Systems (KRMD) Competitors

KRMD vs. CBLL, TCMD, BWAY, ANGO, and BBNX

How does KORU Medical Systems compare to CeriBell?

Does the media refer more to CBLL or KRMD?

Is CBLL or KRMD more profitable?

Which has higher earnings and valuation, CBLL or KRMD?

Do analysts recommend CBLL or KRMD?

Do insiders & institutionals have more ownership in CBLL or KRMD?

Which has more volatility and risk, CBLL or KRMD?

Summary

How does KORU Medical Systems compare to Tactile Systems Technology?

Do insiders & institutionals hold more shares of KRMD or TCMD?

Which has more risk & volatility, KRMD or TCMD?

Which has preferable valuation and earnings, KRMD or TCMD?

Does the media refer more to KRMD or TCMD?

Is KRMD or TCMD more profitable?

Do analysts rate KRMD or TCMD?

Summary

How does KORU Medical Systems compare to Brainsway?

Do analysts prefer BWAY or KRMD?

Which has more risk and volatility, BWAY or KRMD?

Is BWAY or KRMD more profitable?

Which has stronger valuation & earnings, BWAY or KRMD?

Does the media favor BWAY or KRMD?

Do insiders & institutionals have more ownership in BWAY or KRMD?

Summary

How does KORU Medical Systems compare to AngioDynamics?

Does the media refer more to KRMD or ANGO?

Which has more risk & volatility, KRMD or ANGO?

Which has higher earnings & valuation, KRMD or ANGO?

Is KRMD or ANGO more profitable?

Do insiders & institutionals have more ownership in KRMD or ANGO?

Do analysts recommend KRMD or ANGO?

Summary

How does KORU Medical Systems compare to Beta Bionics?

Does the media refer more to KRMD or BBNX?

Do analysts rate KRMD or BBNX?

Which has more volatility and risk, KRMD or BBNX?

Is KRMD or BBNX more profitable?

Which has better valuation & earnings, KRMD or BBNX?

Do institutionals and insiders believe in KRMD or BBNX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KRMD vs. The Competition

KORU Medical Systems Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools